Novartis Wins FDA Approval for CAR-T; So Why Is Gilead Getting a Boost?
August 30, 2017 at 12:38 PM EDT
The landmark FDA ruling makes Novartis the first drug maker to win approval for a new class of cancer drug. Investors, however, see the news as reason to cheer Gilead’s latest acquisition.
